Connect with us

coronavirus

Coronavirus: A timeline of EU action in 2021

SHARE:

Published

5 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

 

Check out our timeline to find out how the EU is tackling the impact of the coronavirus pandemic in 2021. Discover what action the EU is taking in 2021 for the roll-out of vaccines and treatment, to boost the economy, employment, society, travel and transport and to help its partners worldwide to fight COVID-19.

You can also check out our 2020 coronavirus timeline. Covid-19 timeline 2021  description: Follow the events of 2021   Vaccines and treatment Economy Employment and society Travel and transport 10-02-2021

MEPs call for urgent measures to ramp up vaccine production

title short description: The EU must continue its concerted efforts to fight the Covid-19 pandemic and take urgent measures to ramp up vaccine production, MEPs say in a plenary debate. Tag:Vaccines and treatment

10-02-2021

Recovery and Resilience Facility adopted

title short description: Parliament adopts the €672.5 billion Recovery and Resilience Facility, the flagship programme in the Covid-19 recovery plan, to support EU countries in mitigating the economic and social consequences of the pandemic and prepare EU economies for a sustainable, digital future. Tag:Economy

10-02-2021

Relief measures for aviation

title short description: Parliament adopts an agreement with member states allowing airlines to use at least 50% of their planned take-off and landing slots for the 2021 summer and winter seasons, instead of the 80% required before the pandemic. The "use it or lose it" rule had already been temporarily suspended in March 2020 to avoid airlines operating empty flights. Tag:Travel and transport

Advertisement

05-02-2021

Transparency about vaccine supplies

title short description: Parliament’s public health committee asks for transparent data on the number of vaccine doses supplied a for each country as well as the vaccination schedule on a monthly basis, to avoid disinformation. Tag:Vaccines and treatment

29-01-2021

Mechanism for exports of Covid-19 vaccines

title short description: Companies that have concluded Advance Purchased Agreements with the EU have to notify member state authorities about any plans to export vaccines produced in the EU. Tag:Vaccines and treatment

29-01-2021

AstraZeneca vaccine authorised

title short description: A Covid-19 vaccine developed by AstraZeneca is granted a conditional marketing authorisation. It is the third vaccine authorised, following a positive scientific recommendation by the European Medicines Agency. Tag:Vaccines and treatment

28-01-2021

Guidelines on proof of vaccination

title short description: EU countries adopt guidelines on proof of vaccination that could be used if they decide to deploy vaccination certificates in order to make them interoperable. Tag:Vaccines and treatment

28-01-2021

Flexibility under state aid rules

title short description: The European Commission adopts temporary measures allowing EU countries to provide grants, loans and safeguards to companies to help support the economy during the crisis. Tag:Economy

21-01-2021

Aid for those in need

title short description: Parliament adopts an agreement to make additional resources available in 2021 and 2022 to provide food and basic assistance to the most deprived. Tag:Employment and society

19-01-2021

Call for more solidarity and transparency

title short description: MEPs call for more unity and clarity during a debate on the roll-out of vaccines and the EU's vaccines strategy. Tag:Vaccines and treatment

08-01-2021

Up to 300 million additional doses of BioNTech/Pfizer vaccine

title short description: EU member states can purchase an additional 200 million doses of the Covid-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses. Tag:Vaccines and treatment

06-01-2021

Moderna vaccine authorised

title short description: A Covid-19 vaccine developed by Moderna is granted a conditional market authorisation in the EU. It is the second vaccine authorised, following a positive scientific recommendation by the European Medicines Agency. Tag:Vaccines and treatment

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending